Clinical Trial Update: Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing cobicistat-boosted atazanavir versus ritonavir-boosted atazanavir, each with emtricitabine/tenofovir disoproxil fumarate, in AR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• REYATAZ (atazanavir)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
• Tybost (Cobicistat)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2014-10-28